MIF induces osteoclast differentiation and contributes to progression of periodontal disease in mice
- PMID: 22016007
- DOI: 10.1016/j.micinf.2011.09.005
MIF induces osteoclast differentiation and contributes to progression of periodontal disease in mice
Abstract
Periodontal disease (PD) is a chronic inflammatory and alveolar bone destructive disease triggered by microorganisms from the oral biofilm. Oral inoculation of mice with the periodontopathogen Aggregatibacter actinomycetemcomitans (Aa) induces marked alveolar bone loss and local production of inflammatory mediators, including Macrophage Migration Inhibitory Factor (MIF). The role of MIF for alveolar bone resorption during PD is not known. In the present study, experimental PD was induced in BALB/c wild-type mice (WT) and MIF knockout mice (MIF⁻/⁻) through oral inoculation of Aa. Despite enhanced number of bacteria, MIF⁻/⁻ mice had reduced infiltration of TRAP-positive cells and reduced alveolar bone loss. This was associated with decreased neutrophil accumulation and increased levels of IL-10 in periodontal tissues. TNF-α production was similar in both groups. In vitro, LPS from Aa enhanced osteoclastic activity in a MIF-dependent manner. In conclusion, MIF has role in controlling bacterial growth in the context of PD but contributes more significantly to the progression of bone loss during PD by directly affecting differentiation and activity of osteoclasts.
Copyright © 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
Platelet-activating factor receptor blockade ameliorates Aggregatibacter actinomycetemcomitans-induced periodontal disease in mice.Infect Immun. 2013 Nov;81(11):4244-51. doi: 10.1128/IAI.01046-13. Epub 2013 Sep 3. Infect Immun. 2013. PMID: 24002061 Free PMC article.
-
Effect of Lithothamnium sp and calcium supplements in strain- and infection-induced bone resorption.Angle Orthod. 2014 Nov;84(6):980-8. doi: 10.2319/080313-579.1. Epub 2014 Apr 15. Angle Orthod. 2014. PMID: 24731063 Free PMC article.
-
Protective effects of the angiotensin type 1 receptor antagonist losartan in infection-induced and arthritis-associated alveolar bone loss.J Periodontal Res. 2015 Dec;50(6):814-23. doi: 10.1111/jre.12269. Epub 2015 Mar 5. J Periodontal Res. 2015. PMID: 25753377
-
Immune response: the key to bone resorption in periodontal disease.J Periodontol. 2005 Nov;76(11 Suppl):2033-41. doi: 10.1902/jop.2005.76.11-S.2033. J Periodontol. 2005. PMID: 16277573 Review.
-
The role of MIF in periodontitis: A potential pathogenic driver, biomarker, and therapeutic target.Oral Dis. 2024 Apr;30(3):921-937. doi: 10.1111/odi.14558. Epub 2023 Mar 21. Oral Dis. 2024. PMID: 36883414 Review.
Cited by
-
SOCS2 regulates alveolar bone loss in Aggregatibacter actinomycetemcomitans-induced periodontal disease.Inflamm Res. 2023 Apr;72(4):859-873. doi: 10.1007/s00011-023-01711-5. Epub 2023 Mar 13. Inflamm Res. 2023. PMID: 36912916
-
Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.J Bone Miner Res. 2016 Sep;31(9):1688-700. doi: 10.1002/jbmr.2854. Epub 2016 Jun 2. J Bone Miner Res. 2016. PMID: 27082509 Free PMC article.
-
Association between periodontal disease and inflammatory arthritis reveals modulatory functions by melanocortin receptor type 3.Am J Pathol. 2014 Aug;184(8):2333-41. doi: 10.1016/j.ajpath.2014.04.009. Epub 2014 Jun 27. Am J Pathol. 2014. PMID: 24979595 Free PMC article.
-
Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.Cytokine. 2015 Apr;72(2):135-45. doi: 10.1016/j.cyto.2014.11.015. Epub 2015 Jan 31. Cytokine. 2015. PMID: 25647268 Free PMC article.
-
Human variation in gingival inflammation.Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):e2012578118. doi: 10.1073/pnas.2012578118. Proc Natl Acad Sci U S A. 2021. PMID: 34193520 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous